PRECIGEN, INC. 4

President and CEO Helen Sabzevari had 20,833 RSUs vest into Precigen, Inc. common stock, with 10,184 shares withheld for taxes, resulting in 3,779,521 shares owned directly.

On August 23, 2026, Precigen, Inc. President and CEO Helen Sabzevari had 20,833 restricted stock units vest and convert into an equivalent number of shares of common stock, increasing her directly held position to 3,789,705 shares before tax withholding. In connection with this vesting, the issuer withheld 10,184 shares of common stock at an implied price of $7.20 per share to satisfy income tax obligations, leaving Sabzevari with 3,779,521 shares owned directly after the Form 4 transactions. The RSU vest represents 1/24 of a larger RSU grant originally awarded on June 26, 2025, and is consistent with a scheduled compensation vesting event rather than an open‑market purchase or discretionary sale.

Filing Facts

CIK

1356090

Ticker

PGEN

Form

4

Source Type

fda

Accession

0000950103-26-012870

Alert Tier

5